QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Osprey who wrote (1077)	10/13/2000 9:59:53 AM
From: Ian@SI	Read Replies (1) of 1321

IMO, it's a nobrainer. More than 500,000 new cases occur annually. That number is growing as the boomers move further into the danger years. QLT is the only game in town and will remain so for probably another 2 years. After that, the wavelength of the installed lasers only activates VisuDyne. What retinal specialist is going to buy another, redundant piece of equipment which provides no incremental treatment benefits or revenue opportunity? QLT is guiding analysts to $600M by 2003. I'd expect them to reach that runrate before the end of 2001; and exceed the 2003 guidance during 2002. I just can't imagine anyone who is slowly or rapidly going blind not availing themselves of the only treatment which gives them any hope of preserving their eyesight. But I didn't survey any specialists. I just watched a parent go blind from the disease. FWIW, Ian.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next